Pacific Biosciences Of California (PACB) Total Debt (2010 - 2023)

Pacific Biosciences Of California has reported Total Debt for 13 years, with the latest figure at $500000.0 in Q4 2023.

• On a quarterly basis, Total Debt fell 99.72% year-over-year to $500000.0 in Q4 2023; TTM through Dec 2023 was $500000.0, a 99.72% decrease from a year earlier, with the FY2023 full-year figure at $500000.0, down 99.72% from the prior year.
• Total Debt was $500000.0 for Q4 2023 at Pacific Biosciences Of California, down from $96.2 million in the prior quarter.
• The five-year high for Total Debt was $645.3 million in Q2 2023, with the low at $500000.0 in Q4 2023.
• Average Total Debt over 4 years is $118.7 million, with a median of $23.6 million recorded in 2019.
• The sharpest annual moves came in 2022 and 2023: Total Debt jumped 2376.62% in 2022, then tumbled 99.72% in 2023.
• Over 4 years, Total Debt stood at $31.7 million in 2019, then slumped by 77.53% to $7.1 million in 2021, then surged by 2376.62% to $176.2 million in 2022, then sank by 99.72% to $500000.0 in 2023.
• The last three Total Debt figures came in at $500000.0 (Q4 2023), $96.2 million (Q3 2023), and $645.3 million (Q2 2023), per Business Quant data.